about
Mesoniviruses are mosquito-specific viruses with extensive geographic distribution and host rangeAn Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors.The role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infectionExtended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine CandidateModeling Zika Virus Infection in MiceFever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virusEarly Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon ProductionMosquitoes Put the Brake on Arbovirus Evolution: Experimental Evolution Reveals Slower Mutation Accumulation in Mosquito Than Vertebrate CellsEngineered Aedes aegypti JAK/STAT Pathway-Mediated Immunity to Dengue VirusA cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika VaccineUnderstanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional AnalysisDifferential Responses of Human Fetal Brain Neural Stem Cells to Zika Virus InfectionA chikungunya fever vaccine utilizing an insect-specific virus platformA live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse modelsVariation in Aedes aegypti Mosquito Competence for Zika Virus TransmissionHost oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.Development of Vaccines for Chikungunya Fever.Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein.Negevirus: a proposed new taxon of insect-specific viruses with wide geographic distribution.IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safetyIRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol ChallengeEmergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.Differential Vector Competency of Aedes albopictus Populations from the Americas for Zika Virus.Viral Retinopathy in Experimental Models of Zika Infection.Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.Insect-Specific Viruses: A Historical Overview and Recent Developments.Zika Virus Vector Competency of Mosquitoes, Gulf Coast, United States.Outbreak of Zika Virus Infection, Chiapas State, Mexico, 2015, and First Confirmed Transmission by Aedes aegypti Mosquitoes in the Americas.Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo.Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage.Outcomes of Congenital Zika Disease Depend on Timing of Infection and Maternal-Fetal Interferon Action.Functional Analysis of Glycosylation of Zika Virus Envelope Protein.Experimental Zika Virus Infection of Neotropical Primates.Zika virus infection elicits auto-antibodies to C1q.Age and Gender in the Zika Pandemic Era.Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.
P50
Q21245145-ED9491E9-4E1F-4354-A73F-E019C579A216Q24261403-DDF739AE-2954-4F16-A9B7-58FCAD832C38Q24276417-D9C7CDAA-2BB5-4C95-9D47-86434A21FFB5Q24276430-238BDFA7-6DE8-43F6-AA1F-BDD8061FD30EQ26247307-2DBDF70F-AB3F-4177-8C39-B0C1932CEA96Q26864533-0A8AD0B3-78F4-417F-AEB8-99A67E2E612BQ27481032-C2BC96FF-F71A-4C14-B980-BCF46BE53D69Q27488421-223E1C20-A440-4BED-A765-717902AFC739Q28595385-3AA6CE2C-A4F4-428D-9EAC-5A46F76A3EC5Q28729772-7E87C948-EDF9-431A-B1E6-DE5EF90BB2F2Q28735954-74AB9FB6-8B9E-423D-8395-2A42201D8884Q28804095-A4172D7C-DAA6-4941-99CD-5795C1F91616Q28954709-1222A7B0-04D9-43C6-BD2C-C944CE2D79A5Q29352360-7AD4A11E-E1D0-4D3B-9AF5-002748431353Q29365410-6A79DCD6-8E24-4DBD-90A4-6458F6BECC3FQ30145663-58802148-D696-4D0C-86C6-91956CCA20E9Q30240191-E9358397-8F25-488D-B972-5ACF79CBD29BQ30402859-F278C605-D657-4F5D-9270-9914692535C2Q33911897-728E4662-4632-40CF-8849-786B3DBD945DQ34264257-3EF26F04-8624-4932-AEDA-8565B8E61493Q34518777-9408ACC5-CAA5-4CB1-9DE2-F85CE1D2DEB6Q34723422-98834BF4-0615-40A8-80EB-32F9B7B5F119Q35644626-D207EA17-516B-4592-8C65-FA79E811EEE4Q36756643-F02C2127-E9F9-4E2A-9C3B-31638CF49711Q37156478-54A567BA-1242-4E1F-BAC2-F89885BCB646Q38156637-A46AFCD4-F9D7-45C4-A1F4-AF5911F99522Q38156739-E3364252-A890-4CA2-85C2-F264894A6D56Q38157833-7C35A301-EE3B-422E-9820-C05681F3ADE9Q39411421-4A233424-065B-44BF-89A9-A266B7AF693CQ40051335-58CC929A-53D6-41C3-AF40-46990FC69752Q40056614-163DC1BF-197D-43EB-83DB-95C22340C40EQ40154937-B678C3BD-C15D-4D89-93C4-236B638024C1Q40475331-90CF804B-3168-4B92-B9F2-4F119C669144Q41689803-778B08DE-74AF-4C59-BE23-4D3A80D3D89CQ43046627-76255687-4FFF-43A5-8194-067754034CC1Q43046946-7232F04C-E02D-43AF-BCA5-FA721C9B7CDBQ45324156-C40D2FE9-EB34-4E16-8D89-A730CCB41D3CQ47547783-F7DB7918-6AF8-445B-90DC-9CCCE43024FCQ47558649-EDD015B2-D9E1-45C3-8741-92032D146416Q52671193-23F844E9-6372-436B-B4D5-C1774F97615F
P50
description
onderzoeker
@nl
name
Shannan L Rossi
@ast
Shannan L Rossi
@en
Shannan L Rossi
@nl
Shannan L Rossi
@sl
type
label
Shannan L Rossi
@ast
Shannan L Rossi
@en
Shannan L Rossi
@nl
Shannan L Rossi
@sl
prefLabel
Shannan L Rossi
@ast
Shannan L Rossi
@en
Shannan L Rossi
@nl
Shannan L Rossi
@sl